Skip to content

Clinical trials

Observational Essential Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Essential Hypertension Phase: Observational Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20062
20075
20081
20103
20112
20121
20133
20142
20155
20162
20173
20186
20195
20202
20213
20226
20234
20243
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Unknown status16
Recruiting7
Active, not recruiting4
Not yet recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Boryung Pharmaceutical Co., Ltd5
Josip Juraj Strossmayer University of Osijek4
Assiut University2
Bayer2
Celltrion Pharm, Inc.2
Novartis Pharmaceuticals2
University Hospital Padova2
A.Menarini Asia-Pacific Holdings Pte Ltd1
Abbott1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Essential Hypertension70
Hypertension28
Hyperaldosteronism6
Cardiovascular Diseases5
Adrenocortical Adenoma2
Hypertrophy, Left Ventricular2
Renal Insufficiency2
Acute Coronary Syndrome1
Angina, Stable1
Anxiety Disorders1

Trials

Showing 51 to 70 of 70. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.